Literature DB >> 1700614

Neuroendocrine features of reactive bile ductules in cholestatic liver disease.

T Roskams1, J J van den Oord, R De Vos, V J Desmet.   

Abstract

Various cholestatic liver diseases are accompanied by a striking increase in the number of bile ductules. This so-called ductular reaction is thought to arise both from ductular metaplasia of hepatocytes and from proliferation of pre-existing bile ductules. Previous studies have shown that these reactive bile ductules differ from their normal counterpart in enzyme and immunohistochemical make-up. Using monoclonal antibodies directed to neuroendocrine markers and immunohistochemistry, we found that reactive bile ductules in cholestatic liver disease display neuroendocrine features. In all cases of primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), extrahepatic obstruction, and acute hepatitis A, reactive bile ductules expressed the neural cell adhesion molecule (N-CAM) and reacted with monoclonal antibody A2B5. Both N-CAM and the ganglioside, recognized by A2B5, are restricted to neuroendocrine cells and tissues. In all but four of these cases, the same bile ductules expressed chromogranin-A, present in the matrix of neuroendocrine granules. Furthermore, in three cases of longstanding cholestasis, scattered periportal hepatocytes expressed chromogranin-A but not N-CAM. Other neuroendocrine markers such as neuron-specific enolase, synaptophysin, or myelin-associated glycoprotein were lacking from both bile ductules and hepatocytes. The neuroendocrine phenotype of bile ductules and hepatocytes was confirmed on electronmicroscopy, demonstrating various numbers of dense-cored, neuroendocrine granules near the peripheral cell membrane in bile ductules as well as in cells intermediate between hepatocytes and bile ductular cells. In 10 cases of normal liver tissue without ductular reaction, bile ductules lacked neuroendocrine markers except in two cases in which very weak reactivity for chromogranin-A was observed. These findings illustrate the presence of a new, neuroendocrine cell type that emerges in the liver during cholestasis. Elucidation of the significance of the neuroendocrine substance(s) produced in the dense cored granules of reactive bile ductules awaits their isolation and characterization. We can speculate that this molecule plays an autocrine or paracrine regulatory role in the process of ductular metaplasia of hepatocytes or growth of bile ductules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700614      PMCID: PMC1877682     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

Review 1.  Biochemistry of the chromogranin A protein family.

Authors:  J P Simon; D Aunis
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

Review 2.  Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.

Authors:  B Wiedenmann; W B Huttner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

3.  Expression of the neural cell adhesion molecule NCAM in endocrine cells.

Authors:  O K Langley; M C Aletsee-Ufrecht; N J Grant; M Gratzl
Journal:  J Histochem Cytochem       Date:  1989-06       Impact factor: 2.479

4.  Adhesion of neural cells to extracellular matrix constituents. Involvement of glycosaminoglycans and cell adhesion molecules.

Authors:  W Werz; M Schachner
Journal:  Brain Res       Date:  1988-10-01       Impact factor: 3.252

Review 5.  Current problems in diagnosis of biliary disease and cholestasis.

Authors:  V J Desmet
Journal:  Semin Liver Dis       Date:  1986-08       Impact factor: 6.115

6.  The peribiliary portal system in the rabbit liver.

Authors:  O Ohtani
Journal:  Arch Histol Jpn       Date:  1979-04

7.  Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues.

Authors:  R V Lloyd; A Iacangelo; L E Eiden; M Cano; L Jin; M Grimes
Journal:  Lab Invest       Date:  1989-04       Impact factor: 5.662

8.  Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles.

Authors:  B Wiedenmann; W W Franke
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

9.  Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.

Authors:  L L Lanier; R Testi; J Bindl; J H Phillips
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  Cell surface modulation of the neural cell adhesion molecule resulting from alternative mRNA splicing in a tissue-specific developmental sequence.

Authors:  B A Murray; G C Owens; E A Prediger; K L Crossin; B A Cunningham; G M Edelman
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

View more
  37 in total

1.  Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.

Authors:  Sharon DeMorrow; Paolo Onori; Julie Venter; Pietro Invernizzi; Gabriel Frampton; Mellanie White; Antonio Franchitto; Shelley Kopriva; Francesca Bernuzzi; Heather Francis; Monique Coufal; Shannon Glaser; Giammarco Fava; Fanyin Meng; Domenico Alvaro; Guido Carpino; Eugenio Gaudio; Gianfranco Alpini
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

2.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

4.  Synaptophysin: A novel marker for human and rat hepatic stellate cells.

Authors:  D Cassiman; J van Pelt; R De Vos; F Van Lommel; V Desmet; S H Yap; T Roskams
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction.

Authors:  R De Vos; V Desmet
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

6.  CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.

Authors:  I Gütgemann; S Haas; J P Berg; H Zhou; R Büttner; H-P Fischer
Journal:  Virchows Arch       Date:  2006-01-13       Impact factor: 4.064

7.  Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas.

Authors:  T Terada; Y Kitamura; T Ohta; Y Nakanuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

Review 8.  Cholangiocyte proliferation and liver fibrosis.

Authors:  Shannon S Glaser; Eugenio Gaudio; Tim Miller; Domenico Alvaro; Gianfranco Alpini
Journal:  Expert Rev Mol Med       Date:  2009-02-25       Impact factor: 5.600

9.  Pancreatic enzymes in the epithelium of intrahepatic large bile ducts and in hepatic bile in patients with extrahepatic bile duct obstruction.

Authors:  T Terada; T Morita; M Hoso; Y Nakanuma
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

10.  Integrins as differential cell lineage markers of primary liver tumors.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.